Perfluorooctanesulfonate (PFOS) Perturbs Male Rat Sertoli Cell Blood-Testis Barrier Function by Affecting F-Actin Organization via p-FAK-Tyr407: An in Vitro Study

Endocrinology

Volumn 155, Issue 1, 2014, Pages 249-262

  Wan, Hin Ting ^a   Mruk, Dolores D ^a   Wong, Chris K C ^b   Cheng, C Yan ^a  

^a POPULATION COUNCIL   (United States)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CONNEXIN 43; F ACTIN; FOCAL ADHESION KINASE; MICRO RNA 135B; MICRORNA; PERFLUOROOCTANESULFONIC ACID; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD TESTIS BARRIER; CELL COMMUNICATION; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GAP JUNCTION; GENETIC TRANSFECTION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPRODUCTION; SERTOLI CELL; TIGHT JUNCTION;

EID: 84891456107     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1657     Document Type: Article

References (60)

1. Janecki A, Jakubowiak A, Steinberger A. Effect of cadmium chloride on transepithelial electrical resistance of Sertoli cell monolayers in two-compartment cultures -A new model for toxicological investigations of the "blood-testis" barrier in vitro. Toxicol Appl Pharmacol. 1992;112:51-57.
2. Chung NPY, Cheng CY. Is cadmium chloride-induced inter-Sertoli tight junction permeability barrier disruption a suitable in vitro model to study the events of junction disassembly during spermatogenesis in the rat testis? Endocrinology. 2001;142:1878-1888.
3. Setchell BP, Waites GMH. Changes in the permeability of the testicular capillaries and of the "blood-testis barrier" after injection of cadmium chloride in the rat. J Endocrinol. 1970;47:81-86.
4. Wong CH, Mruk DD, Lui WY, Cheng CY. Regulation of bloodtestis barrier dynamics: an in vivo study. J Cell Sci. 2004;117:783-798.
5. Wong CH, Mruk DD, Siu MKY, Cheng CY. Blood-testis barrier dynamics are regulated by -2-macroglobulin via the c-Jun N-terminal protein kinase pathway. Endocrinology. 2005;146:1893-1908.
6. Siu ER, Wong EWP, Mruk DD, Sze KL, Porto CS, Cheng CY. An occludin-focal adhesion kinase protein complex at the blood-testis barrier: a study using the cadmium model. Endocrinology. 2009; 150:3336-3344.
7. Paul AG, Jones KC, Sweetman AJ. A first global production, emission, and environmental inventory for perfluorooctane sulfonate. Environ Sci Technol. 2009;43:386-392.
8. Betts KS. Perfluoroalkyl acids: what is the evidence telling us? Environ Health Perspect. 2007;115:A250-A256.
9. Kennedy GLJ, Butenhoff JL, Olsen GW, et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol. 2004;34:351-384.
10. Peden-AdamsMM,Stuckey JE, Gaworecki KM, et al. Developmental toxicity in white leghorn chickens following in ovo exposure to perfluorooctane sulfonate (PFOS). Reprod Toxicol. 2009;27:307-318.
11. Hoffman K, Webster TF, Weisskopf MG, Weinberg J, Vieira VM. Exposure to polyfluoroalkyl chemi acls and attention deficit hyperactivity disorder in US children aged 12-15 years. Environ Health Perspect. 2010;118:1762-1767.
12. Michalik L, Auwerx J, Berger JP, et al. International Union of Pharmacology. LXI. Peroxisome proliferator-Activated receptors. Pharmacol Rev. 2006;58:726-741.
13. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med. 2002;53:409-435.
14. Olsen GW, Huang HY, Helzlsouer KJ, Hansen KJ, Butenhoff JL, Mandel JH. Historical comparison of perfluorooctanesulfonate, perfluoroocltanoate, and other fluorochemicals in human blood. Environ Health Perspect. 2005;113:539-545.
15. Wan HT, Mruk DD, Wong CKC, Cheng CY. Targeting testis-specific proteins to inhibit spermatogenesis -lesson from endocrine disrupting chemicals. Expert Opin Ther Targets. 2013;17:839-855.
16. Butenhoff JL, Olsen GW, Pfahles-Hutchens A. The applicability of biomonitoring data for perfluorooctanesulfonate to the environment public health continuum. Environ Health Perspect. 2006;114: 1776-1782.
17. Lie PPY, Mruk DD, Mok KW, Su L, Lee WM, Cheng CY. Focal adhesion kinase-Tyr407 and -Tyr397 exhibit antagonistic effects on blood-testis barrier dynamics in the rat. Proc Natl Acad Sci USA. 2012;109:12562-12567.
18. Mruk DD, Cheng CY. An in vitro system to study Sertoli cell bloodtestis barrier dynamics. Methods Mol Biol. 2011;763:237-252.
19. Galdieri M, Ziparo E, Palombi F, Russo MA, Stefanini M. Pure Sertoli cell cultures: a new model for the study of somatic-germ cell interactions. J Androl. 1981;2:249-254.
20. Lee NPY, Mruk DD, Conway AM, Cheng CY. Zyxin, axin, and Wiskott-Aldrich syndrome protein are adaptors that link the cadherin/catenin protein complex to the cytoskeleton at adherens junctions in the seminiferous epithelium of the rat testis. J Androl. 2004; 25:200-215.
21. LiMWM,Mruk DD, LeeWM,Cheng CY. Disruption of the bloodtestis barrier integrity by bisphenolAin vitro: is this a suitable model for studying blood-testis barrier dynamics? Int J Biochem Cell Biol. 2009;41:2302-2314.
22. Lie PPY, Cheng CY, Mruk DD. Cross talk between desmoglein-2/desmocollin- 2/Src kinase and coxsackie and adenovirus receptor/ZO-1 protein complexes, regulates blood-testis barrier dynamics. Int J Biochem Cell Biol. 2010;42:975-986.
23. Lee NPY, Cheng CY. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3,5-cyclic guanosine monophosphate/protein kinaseGsignaling pathway: an in vitro study. Endocrinology. 2003;144:3114-3129.
24. Vallejo AN, Pogulis RJ, Pease LR. PCR mutagenesis by overlap extension and gene SOE. CSH Protoc 2008;2008:pdb.prot4861.
25. MrukDD,WongCH,Silvestrini B, Cheng CY.Amale contraceptive targeting germ cell adhesion. Nat Med. 2006;12:1323-1328.
26. Chung NPY, Mruk DD, Mo MY, Lee WM, Cheng CY. A 22-Amino acid synthetic peptide corresponding to the second extracellular loop of rat occludin perturbs the blood-testis barrier and disrupts spermatogenesis reversibly in vivo. Biol Reprod. 2001;65:1340-1351.
27. Linsen SE, de Wit E, de Bruijn E, Cuppen E. Small RNA expression and strain specificity in the rat. BMC Genomics. 2010;11:249.
28. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on smallRNAlibrary sequencing. Cell. 2007; 29:1401-1414.
29. Qian X, Mruk DD, Wong EWP, Lie PPY, Cheng CY. Palladin is a regulator of actin filament bundles at the ectoplasmic specialization in the rat testis. Endocrinology. 2013;154:1907-1920.
30. Su WH, Wong EWP, Mruk DD, Cheng CY. The Scribble/Lgl/Dlg polarity protein complex is a regulator of blood-testis barrier dynamics and spermatid polarity during spermatogenesis. Endocrinology. 2012;153:6041-6053.
31. Li MWM, Mruk DD, Lee WM, Cheng CY. Connexin 43 is critical to maintain the homeostasis of blood-testis barrier via its effects on tight junction reassembly. Proc Natl Acad Sci USA. 2010;107: 17998-18003.
32. Mok KW, Mruk DD, Lee WM, Cheng CY. Rictor/mTORC2 regulates blood-testis barrier dynamics via its effects on gap junction communications and actin filament network. FASEB J. 2013;27: 1137-1152.
33. Xiao X, Mruk DD, Cheng CY. c-Yes regulates cell adhesion at the apical ectoplasmic specialization-blood-testis barrier axis via its effects on protein recruitment and distribution. Am J Physiol Endocrinol Metab. 2013;304:E145-E159.
34. Mruk DD, Cheng CY. Enhanced chemiluminescence (ECL) for routine immunoblotting. An inexpensive alternative to commercially available kits. Spermatogenesis. 2011;1:121-122.
35. Byers S, Hadley MA, Djakiew D, Dym M. Growth and characterdoi: ization of epididymal epithelial cells and Sertoli cells in dual environment culture chambers. J Androl. 1986;7:59-68.
36. Janecki A, Steinberger A. Polarized Sertoli cell functions in a new two-compartment culture system. J Androl. 1986;7:69-71.
37. Cheng CY, Mruk DD. The blood-testis barrier and its implication in male contraception. Pharmacol Rev. 2012;64:16-64.
38. Kaitu'u-Lino TJ, Sluka P, Foo CF, Stanton PG. Claudin-11 expression and localisation is regulated by androgens in rat Sertoli cells in vitro. Reproduction. 2007;133:1169-1179.
39. Nicholls PK, Harrison CA, Gilchrist RB, Farnworth PG, Stanton PG. Growth differentiation factor 9 is a germ cell regulator of Sertoli cell function. Endocrinology. 2009;150:2481-2490.
40. Du M, Young J, De Asis M, et al. A novel subcellular machine contributes to basal junction remodeling in the seminiferous epithelium. Biol Reprod. 2013;88:60.
41. Lui WY, Wong CH, Mruk DD, Cheng CY. TGF-α3 regulates the blood-testis barrier dynamics via the p38 mitogen activated protein (MAP) kinase pathway: an in vivo study. Endocrinology. 2003;144: 1139-1142.
42. Su L, Mruk DD, Lie PPY, Silvestrini B, Cheng CY.Apeptide derived from laminin-α3 reversibly impairs spermatogenesis in rats. Nat Communs. 2012;3:1185.
43. Li MWM, Mruk DD, Lee WM, Cheng CY. Connexin 43 and plakophilin-2 as a protein complex that regulates blood-testis barrier dynamics. Proc Natl Acad Sci USA. 2009;106:10213-10218.
44. Tate AW, Lung T, Radhakrishnan A, Lim SD, Lin X, Edlund M. Changes in gap junctional connexin isoforms during prostate cancer progression. Prostate. 2006;66:19-31.
45. Siu MKY, Mruk DD, Lee WM, Cheng CY. Adhering junction dynamics in the testis are regulated by an interplay of -1-integrin and focal adhesion complex (FAC)-Associated proteins. Endocrinology. 2003;144:2141-2163.
46. Melzer D, Rice D, Depledge MH, Henley WE, Galloway TS. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the US National Health and Nutrition Examination Survey. Environ Health Perspect. 2010;118:686-692.
47. Song M, Kim YJ, Park YK, Ryu JC. Changes in thyroid peroxidase activity in response to various chemicals. J Environ Monit. 2012; 14:2121-2126.
48. Wan Ibrahim WN, Tofighi R, Onishchenko N, et al. Perfluorooctane sulfonate induces neuronal and oligodendrocytic differentiation in neural stem cells and alters the expression of PPAR-in vitro and in vivo. Toxicol Appl Pharmacol. 2013;269:51-60.
49. Mariussen E. Neurotoxic effects of perfluooralkylated compounds: mechanisms of action and environmental relevance. Arch Toxicol. 2012;86:1349-1367.
50. Wan HT, Zhao YG, Wei X, Hui KY, Giesy JP, Wong CK. PFOSinduced hepatic steatosis, the mechanistic actions on -oxidation and lipid transport. Biochim Biophys Acta. 2012;1820:1092-1101.
51. Wan HT, Zhao YG, Wong MH, et al. Testicular signaling is the potential target of perfluorooctanesulfonate-mediated subfertility in male mice. Biol Reprod. 2011;84:1016-1023.
52. Toft G, Jonsson BA, Lindh CH, et al. Exposure to perfluorinated compounds and human semen quality in Arctic and European populations. Hum Reprod. 2012;27:2532-2540.
53. Rolland M, Le Moal J, Wagner V, Royere D, De Mouzon J. Decline in semen concentration and morphology in a sample of 26 609 men close to general population between 1989 and 2005 in France.Hum Reprod. 2013;28:462-470.
54. Zhang J, Liang J, Zhu H, Li C,WuQ. PFOS andPCB153 have direct adverse effects on neonatal testis modeled using a coculture of primary gonocyte and Sertoli cells. Environ Toxicol. 2011;28:322-331.
55. Qiu L, Zhang X, Zhang X, et al. Sertoli cell is a potential target for perfluorooctane sulfonate-induced reproductive dysfunction in male mice. Toxicol Sci. 2013;135:229-240.
56. Setchell BP. Blood-testis barrier, functional and transport proteins and spermatogenesis. Adv Exp Med Biol. 2008;636:212-233.
57. Smith BE, Braun RE. Germ cell migration across Sertoli cell tight junctions. Science. 2012;338:798-802.
58. Pointis G, Gilleron J, Carette D, Segretain D. Testicular connexin 43, a precocious molecular target for the effect of environmental toxicants on male fertility. Spermatogenesis. 2011;1:303-317.
59. Inoue K, Okada F, Ito R, et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect. 2004;112: 1204-1207.
60. Yeung LW, So MK, Jiang G, et al. Perfluorooctanesulfonate and related fluorochemicals in human blood samples from China. Environ Sci Technol. 2006;40:715-720.